BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36809694)

  • 41. Aerobic Exercise Alleviates Abnormal Autophagy in Brain Cells of APP/PS1 Mice by Upregulating AdipoR1 Levels.
    Jian Y; Yuan S; Yang J; Lei Y; Li X; Liu W
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer's disease via suppression of neuroinflammation.
    Zhou L; Yang C; Liu Z; Chen L; Wang P; Zhou Y; Yuan M; Zhou LT; Wang X; Zhu LQ
    J Ethnopharmacol; 2024 Mar; 321():117569. PubMed ID: 38086513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice.
    Zang C; Liu H; Shang J; Yang H; Wang L; Sheng C; Zhang Z; Bao X; Yu Y; Yao X; Zhang D
    Phytomedicine; 2021 Dec; 93():153780. PubMed ID: 34607163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
    Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway.
    Zhang M; Qian C; Zheng ZG; Qian F; Wang Y; Thu PM; Zhang X; Zhou Y; Tu L; Liu Q; Li HJ; Yang H; Li P; Xu X
    Theranostics; 2018; 8(15):4262-4278. PubMed ID: 30128052
    [No Abstract]   [Full Text] [Related]  

  • 47. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibiting Aβ toxicity in Alzheimer's disease by a pyridine amine derivative.
    Zhu Z; Yang T; Zhang L; Liu L; Yin E; Zhang C; Guo Z; Xu C; Wang X
    Eur J Med Chem; 2019 Apr; 168():330-339. PubMed ID: 30826509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD.
    Li T; Su Q; Zhang Z; Zhang Y; Yang M; Wang Z; Guo J; Wang Z; Wu M; Cai H; Qi J
    Prog Neurobiol; 2022 Aug; 215():102298. PubMed ID: 35671859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer's disease via enhancing autophagic clearance of p-Tau through m6A-dependent regulation of STUB1.
    Tang Z; Cao J; Yao J; Fan X; Zhao J; Zhao M; Duan Q; Han B; Duan S
    Free Radic Biol Med; 2023 Feb; 195():343-358. PubMed ID: 36587923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice.
    Qiu H; Liu X
    Mol Neurobiol; 2022 Aug; 59(8):4987-4999. PubMed ID: 35665898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.
    Wani A; Al Rihani SB; Sharma A; Weadick B; Govindarajan R; Khan SU; Sharma PR; Dogra A; Nandi U; Reddy CN; Bharate SS; Singh G; Bharate SB; Vishwakarma RA; Kaddoumi A; Kumar A
    Autophagy; 2021 Nov; 17(11):3813-3832. PubMed ID: 33404280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.
    Joshi G; Gan KA; Johnson DA; Johnson JA
    Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.
    Tan X; Guan H; Yang Y; Luo S; Hou L; Chen H; Li J
    Toxicol Appl Pharmacol; 2020 Aug; 401():115090. PubMed ID: 32512069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
    J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα.
    Chandra S; Jana M; Pahan K
    J Neurosci; 2018 Jul; 38(30):6682-6699. PubMed ID: 29967008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of PPARα enhances astroglial uptake and degradation of β-amyloid.
    Raha S; Ghosh A; Dutta D; Patel DR; Pahan K
    Sci Signal; 2021 Oct; 14(706):eabg4747. PubMed ID: 34699252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.